Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 4,234,235
- Share change
- -1,590,507
- Total reported value
- $10,372,895
- Price per share
- $2.45
- Number of holders
- 35
- Value change
- -$6,125,369
- Number of buys
- 17
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
1,455,864
|
$8,153,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
2.5%
|
1,205,812
|
$6,753,000 | — | 31 Dec 2017 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.8%
|
881,000
|
$4,934,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
489,752
|
$2,743,000 | — | 31 Dec 2017 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.85%
|
415,279
|
$2,326,000 | — | 31 Dec 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.62%
|
301,000
|
$1,686,000 | — | 31 Dec 2017 | |
| Opus Point Partners Management, LLC |
13F
|
Company |
0.27%
|
133,500
|
$748,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
125,906
|
$705,000 | — | 31 Dec 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.26%
|
125,670
|
$704,000 | — | 31 Dec 2017 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
116,500
|
$652,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
94,205
|
$527,000 | — | 31 Dec 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
68,795
|
$385,000 | — | 31 Dec 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
50,000
|
$280,000 | — | 31 Dec 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
48,400
|
$271,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.1%
|
47,303
|
$265,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
42,473
|
$238,000 | — | 31 Dec 2017 | |
| Mariner, LLC |
13F
|
Company |
0.08%
|
41,525
|
$233,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
33,930
|
$190,000 | — | 31 Dec 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
31,400
|
$176,000 | — | 31 Dec 2017 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
22,911
|
$128,000 | — | 31 Dec 2017 | |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd |
13F
|
Company |
0.04%
|
19,958
|
$112,000 | — | 31 Dec 2017 | |
| BALDWIN WEALTH PARTNERS LLC/MA |
13F
|
Company |
0.04%
|
19,551
|
$109,000 | — | 31 Dec 2017 | |
| FORBES J M & CO LLP |
13F
|
Company |
0.03%
|
15,066
|
$84,000 | — | 31 Dec 2017 | |
| Sandy Spring Bank |
13F
|
Company |
0.02%
|
8,755
|
$49,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
7,634
|
$42,000 | — | 31 Dec 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
6,698
|
$38,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,910
|
$33,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
4,200
|
$24,000 | — | 31 Dec 2017 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
1,354
|
$8,000 | — | 31 Dec 2017 | |
| Cable Hill Partners, LLC |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
391
|
$2,000 | — | 31 Dec 2017 | |
| Winch Advisory Services, LLC |
13F
|
Company |
0%
|
300
|
$2,000 | — | 31 Dec 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
245
|
$1,000 | — | 31 Dec 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3
|
$17 | — | 31 Dec 2017 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q1 2018
As of 31 Mar 2018,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,234,235 shares.
The largest 10 holders included
FMR LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Sio Capital Management, LLC, JPMORGAN CHASE & CO, Opus Point Partners Management, LLC, Alethea Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
33
Q1 2018 holders
35
Holder diff
2
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.